T. Rowe Price Innovation Leaders ETF
TNXT
NASDAQ Global Market- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Joyce F. Lee-Iannotti
- Full Time Employees
- 100
- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 1307 Point Street Baltimore MD United States of America 21231
- IPO Date
- Jan 29, 2026
- Website
- tanvex.com
- Similar Companies
- Business
- T. Rowe Price Exchange-Traded Funds, Inc. is a Maryland-based investment company that serves as the issuer and manager of exchange-traded funds (ETFs) affiliated with T. Rowe Price Group, Inc., focusing on actively managed equity strategies for institutional and retail investors worldwide. The company offers the T. Rowe Price Innovation Leaders ETF (ticker: TNXT), which invests primarily in equity securities of companies demonstrating strong innovation characteristics across sectors such as technology, healthcare, and consumer discretionary; it employs a bottom-up research process to select holdings based on proprietary innovation metrics, revenue growth potential, and competitive moats, with a portfolio typically comprising 30-50 stocks and a focus on mid- to large-cap innovators. Founded in 2020 as part of T. Rowe Price's expansion into the ETF market, the company operates from headquarters in Baltimore, Maryland, with geographic reach through U.S. exchanges and global exposure via its underlying fund holdings in North America, Europe, and Asia; it targets growth-oriented investors seeking alpha generation beyond traditional passive indexing. In recent developments, T. Rowe Price Exchange-Traded Funds, Inc. launched additional active ETFs in 2024, including expansions in dividend growth and blue-chip strategies, amid T. Rowe Price Group, Inc.'s strategic shift toward fee compression responses and increased emphasis on separately managed accounts; no major acquisitions or name changes have occurred within the last two years, though the firm continues to enhance TNXT's innovation theme through portfolio rebalancing to capture emerging leaders in artificial intelligence and biotechnology as of early 2026.